Phoenix, AZ — Phoenix, Arizona

Phoenix, AZ is a clinical research site located in Phoenix, Arizona, United States 85032.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

Phoenix, AZ has participated in 3 clinical trials.

Therapeutic areas: Neovascular Age-related Macular Degeneration (NVAMD), Diabetic Macular Edema (DME), Neovascular (Wet) Age-Related Macular Degeneration.

Sponsors: EyeBiotech Ltd., Ollin Biosciences, Inc., Ocuphire Pharma, Inc..

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Phoenix, AZ?

Phoenix, AZ has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Phoenix, AZ conducted?

Phoenix, AZ has 3 clinical trials on record. Their work covers Neovascular Age-related Macular Degeneration (NVAMD), Diabetic Macular Edema (DME), Neovascular (Wet) Age-Related Macular Degeneration.

Is Phoenix, AZ accredited by Crixeo Health?

Phoenix, AZ has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Phoenix, AZ?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.